Cargando…

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital

Detalles Bibliográficos
Autores principales:	Lesher, Beth A, Liu, Zhengyin, Chen, Yixi, Gao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624059/ https://www.ncbi.nlm.nih.gov/pubmed/26557754 http://dx.doi.org/10.2147/CEOR.S89570

Ejemplares similares

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People’s Republic of China
por: Lesher, Beth, et al.
Publicado: (2016)

Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study
por: Song, Yuanlin, et al.
Publicado: (2014)

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Emergence of linezolid-resistant Enterococcus faecium in a tertiary hospital in Copenhagen
por: Misiakou, Maria-Anna, et al.
Publicado: (2023)

Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
por: Warda, Ahmed E. Abou, et al.
Publicado: (2022)

Low Prevalence of Cfr-Mediated Linezolid Resistance among Methicillin-Resistant Staphylococcus aureus in a Spanish Hospital: Case Report on Linezolid Resistance Acquired during Linezolid Therapy
por: Sierra, Josep M., et al.
Publicado: (2013)

Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children’s hospital in Cracow, Poland
por: Kosecka-Strojek, Maja, et al.
Publicado: (2020)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

Absence of legionellosis in patients with community-acquired pneumonia requiring hospitalization
por: Kühne, Juliana, et al.
Publicado: (2014)

Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae
por: Rup, Amit Ranjan, et al.
Publicado: (2020)

Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia
por: Bhan, Urvashi, et al.
Publicado: (2015)

Molecular Characterization of Clinical Linezolid-Resistant Staphylococcus epidermidis in a Tertiary Care Hospital
por: Campmann, Florian, et al.
Publicado: (2023)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community acquired pneumonia
por: Chen, Dawei, et al.
Publicado: (2021)

Genomic and Phenotypic Analysis of Linezolid-Resistant Staphylococcus epidermidis in a Tertiary Hospital in Innsbruck, Austria
por: Huber, Silke, et al.
Publicado: (2021)

Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital
por: Purba, Abdul KR, et al.
Publicado: (2019)

A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
por: Wunderink, Richard G, et al.
Publicado: (2021)

Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care Hospital
por: Park, Kuenyoul, et al.
Publicado: (2020)

Resistance of gram negative bacteria in hospital acquired pneumonia: a prospective study
por: Dehghan, Farzaneh, et al.
Publicado: (2015)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
por: Merida-Vieyra, Jocelin, et al.
Publicado: (2019)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
por: Montravers, Philippe, et al.
Publicado: (2016)

Linezolid resistance in patients with drug-resistant TB
por: Vengurlekar, D., et al.
Publicado: (2023)

Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
por: Maraki, Sofia, et al.
Publicado: (2014)

Prevalence of linezolid-resistant organisms among patients admitted to a tertiary hospital for critical care or dialysis
por: Dembicka, Kornelia Maria, et al.
Publicado: (2021)

Linezolid a potential treatment for COVID-19 coinfections
por: Moghadam, Vahid Damanpak, et al.
Publicado: (2021)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

COVID-19 Prevention Policies Reduce Pediatric Hospital Mortality Due to Community-acquired Pneumonia
por: Dias, Carolina F., et al.
Publicado: (2022)

A Multicenter Study of Viral Aetiology of Community-Acquired Pneumonia in Hospitalized Children in Chinese Mainland
por: Zhu, Yun, et al.
Publicado: (2021)

S17.3 PK/PD in the treatment of hospital-acquired pneumonia
Publicado: (2005)

1604. Cost-Effectiveness of Ceftazidime-Avibactam for Patients with Hospital-Acquired Pneumonia Caused by Multi-Drug Resistant Enterobacteriaceae or Pseudomonas in China
por: Furnback, Wesley, et al.
Publicado: (2020)

Cortisol total/CRP ratio for the prediction of hospital-acquired pneumonia and initiation of corticosteroid therapy in traumatic brain-injured patients
por: Jia, Linpei, et al.
Publicado: (2020)

Genomic Analysis of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Tertiary Hospital
por: Chen, Lan, et al.
Publicado: (2023)

Comment on Linezolid induced optic neuropathy
por: Patel, Chaitali, et al.
Publicado: (2015)

Etiology of community-acquired and hospital-acquired pneumonia associated with COVID-19
por: Chemisova, O., et al.
Publicado: (2022)

Linezolid-Resistant Staphylococcus cohnii, Greece
por: Petinaki, Efi, et al.
Publicado: (2009)

PP-178 Surveillance of antimicrobial resistance in patients with community acquired pneumonia in tertiary care hospital, Manipal
por: Kadam, Manish S., et al.
Publicado: (2009)

Risk factors for community-acquired pneumonia among inpatients with mental disorders in a tertiary general hospital
por: Han, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pvklg9k790ncbog2mcqkl5kqou